Mary Ann Liebert, Inc.

Ours is a vibrant company (www.liebertpub.com), rich in ideas, determination, and ability to create meaningful publications that contribute to the literature and to the fields they serve. Some examples of Mary Ann Liebert, Inc. publications  include: Genetic Engineering and Biotechnology News, the first, and the most widely-read biotechnology trade publication worldwide. We were also the first to publish a medical journal on AIDS, long before this disease was designated as a serious threat to world health. Another Liebert journal that is first in its field is Human Gene Therapy, the leading journal on this subject matter. Our Telemedicine and e-Health journal  plays an increasingly important role in health care and provide tools that are indispensable for disease management, home health, and remote care that encompasses not only rural health and battlefield care, but nursing home, assisted living facilities, and maritime and aviation applications.  Journal of Women's Health recognized and supported the importance of gender-based medicine, which benefits both men and women, and Alternative & Complementary Therapies provides health care professionals with the information they need to evaluate unconventional therapies and their place in patient care. Biosecurity and Bioterrorism is an example of meeting an urgent need at a critical time. Please visit www.liebertpub.com for a complete listing of our Journals and Books.